ExCulture has an exclusive licence to a mixed culture fermentation bioprocess technology from TU Delft that they are developing as a novel method for producing heparin-like compounds.
Contact details
ExCultureAlexander Fleminglaan 1
2613 AX Delft
The Netherlands